National Cancer Institute, National Institutes of Health
Multiple Myeloma Section
Medical Oncology Branch
9000 Rockville Pike
Bldg 10, Room 12N226
Bethesda, MD 20892
National Cancer Institute (NCI)
1-800-4-CANCER (1-800-422-6237)
http://www.cancer.gov/
http://www.cancer.gov/cancertopics/types/myeloma/
National Institutes of Health (NIH)
301-496-4000
Email: NIHinfo@od.nih.gov
http://www.nih.gov/
http://health.nih.gov/topic/MultipleMyeloma/Cancers
Summary
The NIH, a part of the U.S. Department of Health and Human Services, is the primary Federal agency for conducting and supporting medical research. Helping to lead the way toward important medical discoveries that improve people's health and save lives and composed of 27 Institutes and Centers, the NIH provides leadership and financial support to researchers in every state and throughout the world.
The NIH is headquartered in Bethesda, Maryland, just north of Washington, DC, and has satellite sites across the U.S. With the support of the American people, the NIH annually invests over $28 billion in medical research. Most of the NIH's funding is awarded through competitive grants to researchers at over 3,000 universities, medical schools, and other research institutions in every state and around the world. About 10 percent of the NIH's budget supports projects conducted by nearly 6,000 scientists in its own laboratories, most of which are on the NIH campus in Bethesda, Maryland.
The NCI coordinates the National Cancer Program, which conducts and supports research, training, health information dissemination, and other programs with respect to the cause, diagnosis, prevention, and treatment of cancer, rehabilitation from cancer, and the continuing care of cancer patients and their families.
The Center for Cancer Research (CCR) is home to more than 250 scientists and clinicians working in intramural research at NCI. CCR is part of the Clinical Center at the NIH in Bethesda, Maryland, the largest hospital devoted entirely to clinical research in the U.S. The Clinical Center is a national resource that makes it possible to rapidly translate scientific observations and laboratory discoveries into new approaches for diagnosing, treating, and preventing disease. CCR's investigators are basic, clinical, and translational scientists who work together to advance scientific knowledge and to develop new therapies.
Doctors
The following doctors specialize in hematology/oncology:
C. Ola Landgren, M.D., Ph.D. (websites: CCR Clinical Trials, Cancer for Research Center)
Specialty:
Hematology
Accomplishments:
Head, Multiple Myeloma Section Investigator
Youtube: http://www.youtube.com/watch?v=myc74Nmp9C0
More information on each doctor, including their current research and clinical trials, can be found on their respective Web pages.
Multiple Myeloma Research Team Contact Information
Mary Ann Yancey, R.N.
Research Nurse
yancey@mail.nih.gov
301-435-9227